Kiel Institute For The World Economy 1
1. Reduced insulin use and diabetes complications upon introduction of SGLT-2 inhibitors and GLP1-receptor agonists in low- and middle-income countries: A microsimulation
2. Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019
3. Hypertension care cascades and reducing inequities in cardiovascular disease in low- and middle-income countries
1